These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1095 related items for PubMed ID: 21913440

  • 1. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A, Kowalska K, Jankowska-Lech I, Terelak-Borys B, Nowosielska A, Grabska-Liberek I.
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC.
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB.
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravitreal triamcinolone acetonide: a change in a paradigm.
    Jonas JB.
    Ophthalmic Res; 2006 Dec; 38(4):218-45. PubMed ID: 16763379
    [Abstract] [Full Text] [Related]

  • 8. [Intravitreous injection: retrospective study on 2028 injections and their side effects].
    Angulo Bocco MC, Glacet-Bernard A, Zourdani A, Coscas G, Soubrane G.
    J Fr Ophtalmol; 2008 Sep; 31(7):693-8. PubMed ID: 18971854
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC, Wu WC, Chen KJ.
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X, Li J, Hu X, Yu S, Pan J, Tang S.
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [Abstract] [Full Text] [Related]

  • 11. Ocular morbidity associated with intravitreal triamcinolone acetonide.
    Konstantopoulos A, Williams CP, Newsom RS, Luff AJ.
    Eye (Lond); 2007 Mar; 21(3):317-20. PubMed ID: 16710433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
    Alshareef RA, Garg SJ, Hsu J, Vander J, Park C, Spirn MJ.
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB, Kreissig I, Degenring RF.
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study.
    Isaac DL, Abud MB, Frantz KA, Rassi AR, Avila M.
    Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.